Release Date: 31/03/10 10:15 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 3.06MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%